Paul M. Titchenell, Ph.D.
Assistant Professor of Physiology
Department: Physiology
Graduate Group Affiliations
Contact information
Institute for Diabetes, Obesity, and Metabolism
Smilow Center for Translational Research
3400 Civic Center Blvd, Building 421
Room: 12-104
Philadelphia, PA 19104
Smilow Center for Translational Research
3400 Civic Center Blvd, Building 421
Room: 12-104
Philadelphia, PA 19104
Office: 215-573-1872
Lab: 215-573-1875
Lab: 215-573-1875
Email:
ptitc@pennmedicine.upenn.edu
ptitc@pennmedicine.upenn.edu
Publications
Education:
B.S. (Biochemistry and Molecular Biology)
Dickinson College, 2008.
Ph.D. (Physiology)
Pennsylvania State University, 2013.
B.S. (Biochemistry and Molecular Biology)
Dickinson College, 2008.
Ph.D. (Physiology)
Pennsylvania State University, 2013.
Links
Search PubMed for articles
Physiology Faculty Page
Institute for Diabetes, Obesity, and Metabolism
Titchenell Lab Website
Search PubMed for articles
Physiology Faculty Page
Institute for Diabetes, Obesity, and Metabolism
Titchenell Lab Website
Post-Graduate Training
Postdoctorate Fellow, Institute for Diabetes, Obesity, and Metabolism, Department of Medicine, University of Pennsylvania School of Medicine, 2013-2016.
Permanent linkPostdoctorate Fellow, Institute for Diabetes, Obesity, and Metabolism, Department of Medicine, University of Pennsylvania School of Medicine, 2013-2016.
Description of Research Expertise
Research Interests:Molecular mechanisms of insulin signaling, insulin resistance, and metabolism
Keywords:
metabolism, insulin, diabetes, obesity, AKT, mTORC1
Research Details:
My research interests are focused on the regulation of metabolism by hormones and nutrients, with a particular emphasis on a master regulator of organismal anabolic metabolism, insulin. Alterations in insulin action underlie metabolic disease and lead to the development of deadly vascular and neuronal complications. Through the use of various techniques encompassing molecular biology, biochemistry, metabolomics, genome-wide transcriptional techniques and whole-animal physiology, the long-term goals of my research program are to decipher the underlying mechanisms driving metabolic deregulation during disease and identify new therapies that improve metabolic control.
Current Lab personnel:
Matthew Gavin (Research Specialist)
Natasha Jaiswal Ph.D. (Postdoctoral Researcher)
Jaclyn Welles Ph.D. (Postdoctoral Researcher)
Kahea Uehara (PhD student, BMB graduate group)
Dominic Santoleri (PhD student, BMB graduate group)
Anna Garcia Whitlock M.D. (PhD student, CAMB graduate group)
Megan Stefkovich, (PhD student, CAMB graduate group)
Talia Coopersmith (Penn undergraduate-PURM)
Olivia Ong (Penn undergraduate)
Selected Publications
Sostre-Colón J, Gavin MJ, Santoleri D, Titchenell PM.: Acute Deletion of the FOXO1-dependent Hepatokine FGF21 Does not Alter Basal Glucose Homeostasis or Lipolysis in Mice. Endocrinology 163: bqac035, May 2022.Uehara K, Sostre-Colón J, Gavin M, Santoleri D, Leonard KA, Jacobs RL, Titchenell PM.: Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis. Cell Mol Gastroenterol Hepatol 13: 1625-1647, Feb 2022.
Gosis BS, Wada S, Thorsheim C, Li K, Jung S, Rhoades JH, Yang Y, Brandimarto J, Li L, Uehara K, Jang C, Lanza M, Sanford NB, Bornstein MR, Jeong S, Titchenell PM, Biddinger SB, Arany Z.: Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1. Science 376: eabf8271, Apr 2022.
Sostre-Colón J, Uehara K, Garcia Whitlock AE, Gavin MJ, Ishibashi J, Potthoff MJ, Seale P, Titchenell PM.: Hepatic AKT orchestrates adipose tissue thermogenesis via FGF21-dependent and -independent mechanisms. Cell Rep 35: 109128, May 2021.
Quinn WJ 3rd, Wan M, Shewale SV, Gelfer R, Rader DJ, Birnbaum MJ, Titchenell PM.: mTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion. J Clin Invest 127: 4207-4215, Nov 2017.
Titchenell PM, Quinn WJ, Lu M, Chu Q, Lu W, Li C, Chen H, Monks BR, Chen J, Rabinowitz JD, Birnbaum MJ.: Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production. Cell Metab 23: 1154-1166, Jun 2016.
Titchenell PM, Chu Q, Monks BR, Birnbaum MJ.: Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo. Nat Commun 6: 7078, May 2015.
Contact us
Institute for Diabetes, Obesity and Metabolism
Smilow Center for Translational Research
3400 Civic Center Boulevard, 12th Floor
Philadelphia, PA 19104
Phone: 215-898-0198 | Fax 215-898-5408
Directions
© Trustees of the University of Pennsylvania